2026 annual financial data
China SXT Pharmaceuticals 2026 Operating margin
China SXT Pharmaceuticals 2026 operating margin with verified reported values.
Direct answer
Operating margin was -664.06%.
Operating income was -7,122,933 USD and net income was -6,205,085 USD.
Operating cash flow was -4,017,456 USD.
Get free China SXT Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,072,632 USD
- Operating income
- -7,122,933 USD
- Net income
- -6,205,085 USD
- Operating cash flow
- -4,017,456 USD